1.0Expert Database/oor/expertsAnish Parepalli/oor/experts/author/anishpa/Chengwen Li, PhD | ºÚÁÏÍø Expertscape-ranked Facultyrich600338<blockquote class="wp-embedded-content" data-secret="fnIso0FRQw"><a href="/oor/experts/faculty-expert/chengwen-li/">Chengwen Li, PhD</a></blockquote><iframe sandbox="allow-scripts" security="restricted" src="/oor/experts/faculty-expert/chengwen-li/embed/#?secret=fnIso0FRQw" width="600" height="338" title="“Chengwen Li, PhD” — Expert Database" data-secret="fnIso0FRQw" frameborder="0" marginwidth="0" marginheight="0" scrolling="no" class="wp-embedded-content"></iframe><script type="text/javascript">
/* <![CDATA[ */
/*! This file is auto-generated */
!function(d,l){"use strict";l.querySelector&&d.addEventListener&&"undefined"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!/[^a-zA-Z0-9]/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret="'+t.secret+'"]'),o=l.querySelectorAll('blockquote[data-secret="'+t.secret+'"]'),c=new RegExp("^https?:$","i"),i=0;i<o.length;i++)o[i].style.display="none";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute("style"),"height"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):"link"===t.message&&(r=new URL(s.getAttribute("src")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener("message",d.wp.receiveEmbedMessage,!1),l.addEventListener("DOMContentLoaded",function(){for(var e,t,s=l.querySelectorAll("iframe.wp-embedded-content"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute("data-secret"))||(t=Math.random().toString(36).substring(2,12),e.src+="#?secret="+t,e.setAttribute("data-secret",t)),e.contentWindow.postMessage({message:"ready",secret:t},"*")},!1)))}(window,document);
/* ]]> */
</script>
/oor/experts/wp-content/uploads/sites/1368/2024/02/Chengwen-photo.jpg174234AAV vectors have been successfully applied in clinical trials in patients with eye and liver diseases. Several challenges limit AAV application including the capsid specific CTL response, AAV neutralizing antibody presence in human population, late innate immune response after AAV transduction and low transduction efficiency of AAV vector in humans. In light of our most … Read more